[ACCESSWIRE]
NEW YORK, NY / ACCESSWIRE / June 20, 2016 / Conventional wisdom of the past several decades presumes higher education equates with business success. It's what our children strive for; however, this is not always true. Example: multi-billionaire Mark Zuckerberg dropped out of Harvard University to devote himself to a computer program that became global social phenomenon Facebook.
Likewise for Bill Gates and the late Steve Jobs, two men who, sans formal higher education, succeeded in transforming computing technology. It almost seems that young entrepreneurs, to grab the brass ring of fame and fortune, must be college dropouts!
The other side of the coin: Ivy-leaguer Jeff Bezos forever changed retailing by introducing ecommerce, and don't forget the founders of Intel - one a Rhodes Scholar and the other a Ph.D. in chemistry and physics. There is also Sergey Brin of Google fame who received a graduate degree from Stanford University, on his way to a doctorate.
All this is to say the need for advanced degrees do not necessarily translate into big money. Men mentioned, however, had the energy of the young and passion for their projects. Luck would have nothing to do with accomplishments.
Now the world is introduced to Waqaas Al-Siddiq, a brilliant young Indian-Canadian who founded a medical technology firm called Biotricity Inc. (OTCQB: BTCY) that will revolutionize cardiac monitoring and treatment by relaying meaningful heart data from patient to doctor in real time, at all times, thereby avoiding adverse incidents that could lead to extended hospital stays, and even death.
Mr. Al-Siddiq is, in essence, a hybrid of sorts, possessing a blend of advanced education and energetic zest to make Biotricity a leader in remote wireless heart monitoring for the medical, and more forward-thinking, consumer market, made popular by recent inventions to track exercise and vital statistics where larger competitors' devices have shown drawbacks. Reaching consumers now attuned to wireless technology is part of Mr. Al-Siddiq's broader vision, where he intends to use Biotricity's know-how to alter the consumer healthcare market.
Mr. Al-Siddiq's academic pedigree is astounding: entering university after 8th grade, he completed a dual Bachelor's in Computer Engineering and Economics. Then, two Master's degrees, one in Computer Engineering from the prestigious Rochester Institute of Technology and one in Management - studying how to transform innovation into billion dollar markets, were awarded. All achieved by the age of 19.
Needless to say, Mr. Al-Siddiq was in high demand. Quickly snagged by IBM for a senior design position, he was recruited away by Advanced Micro Devices and then snatched up by Intel. His work has been lauded by global technology leader IEEE and has become part of university textbooks. Mr. Al-Siddiq, despite his young age, is instrumental in guiding projects through his Board seats, and boasts former executive roles in small- and medium-sized companies.
Biotricity's passion to fill a vital healthcare IT gap by bringing doctors and patients closer for better compliance (ultimately lowering burgeoning healthcare costs) drew the attention of Norman Betts, Ph.D., member of Bank of Canada's Board of Directors, who recently joined Biotricity's Board. Dr. Betts understands how Biotricity can, through disruptive technology, change the face of medicine.
Most of the pieces for Biotricity's success are coming together: FDA approval is imminent; reimbursement codes are established; and a go-to-market strategy should produce revenues by year-end. As a strong testimony to Biotricity's future, seed money was raised from a group of physicians.
Media attention is growing. Recently, an article in Forbes detailed Biotricity's work in one of Canada's largest hospitals to determine its device's usefulness in monitoring heart rate variability to predict an adverse cardiac event. Here, wireless technology is key; otherwise, patients would need to present to hospital for a standard ECG that may or may not pinpoint upcoming heart trouble. Results of the study should be published soon and, if positive, will add another value proposition to owning Biotricity shares.
Now more than ever, doctors must use marketing strategies to attract and keep patient-clients. Top-notch technology will lead this charge. Even Presidential hopeful Donald Trump speaks out how doctors must market themselves in coming years.
Biotricity, as a pioneering company with ground-breaking technology targeting multi-billion dollar worldwide markets, is strongly recommended as a stock to closely watch for spectacular future returns.
CONTACT:
Sharon di Stefano
[email protected]
SOURCE: Small Cap Forecasting, Inc.
